H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $67 billion of capital under management, is pleased to announce the sale of its portfolio company, Soleo Health (“Soleo” or the “Company”), to funds managed by Court Square Capital and WindRose Health Investors.
Headquartered in Frisco, TX, Soleo is a diversified, scaled, omnichannel infusion platform, delivering personalized healthcare to patients with complex, rare, and ultra-rare medical conditions. The Company operates 26 pharmacies and more than 30 ambulatory infusion suites across the United States. Through its extensive pharmacy licensure and specialized nursing network, the company serves patients across all 50 states.
Health Technology Insights: Exigent Research Partners with AI Leader ConcertAI to Integrate CARAai Precision Trial Solutions
During its ownership, H.I.G. supported the Company in building an industry-leading specialty pharmacy and infusion business by increasing Soleo’s footprint with de novo pharmacy and infusion suite expansions, introducing a differentiated therapy-specific clinical model, diversifying payor, site-of-care and therapy offerings, and making key executive hires.
Drew Walk, President and Chief Executive Officer at Soleo, commented, “H.I.G. has been an exceptional partner to Soleo and instrumental in helping us build the Company into the market leader we are today. H.I.G. supported several significant investments in talent and infrastructure, strengthening our ability to reach more patients and provide exceptional care across our network.”
Health Technology Insights: UNC Health to Adopt Abridge Technology to Improve Clinical Conversations
Scott Zhu, Managing Director at H.I.G., said, “Drew and the Soleo management team have done an outstanding job transforming Soleo from a regional infusion player into a national specialty care provider, with a variety of compelling growth opportunities. Soleo is an exceptional infusion platform led by a best-in-class leadership team, and we look forward to watching the Company’s continued growth.”
Health Technology Insights: IgniteData Expands EHR-to-EDC Capabilities with Yunu Integration for Imaging Data in Clinical Trials
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – prnewswire
